03 Jan 2022 --- Biotech companies Biosyntia and Lantana Bio have signed an in-licensing deal that will see the creation of a new technology platform. The companies plan to develop a more sustainable production process for flavonoids. Under the agreement, Biosyntia will be in charge of production and commercialization.
